1. MORBIDITY AND MORTALITY IN LONG‐TERM SURVIVORS OF HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE. (12th June 2019) Authors: Gaudio, F.; Perrone, T.; Giordano, A.; Curci, P.; Laddaga, F.; Nardelli, C.; Masciandaro, P.; Colonna, P.; Cicinelli, E.; Specchia, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP). (23rd June 2022) Authors: Mele, A.; Prete, E.; Citiso, S.; Mele, G.; Pastore, D.; Sgherza, N.; Curci, P.; Musto, P.; Falcone, A. P.; Cascavilla, N.; Germano, C.; Giuseppe, T.; Reddiconto, G.; Di Renzo, N.; Palazzo, G.; Mazza, P.; Rossini, B.; Guarini, A.; Palumbo, G.; Melillo, L. M. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY. (23rd June 2022) Authors: Mina, R.; Bonello, F.; Fazio, F.; Saccardi, R.; Bongarzoni, V.; Marchesi, F.; Bertuglia, G.; Curci, P.; Lemoli, R. M.; Ballanti, S.; Dentamaro, T.; Benevolo, G.; Capra, A.; Floris, R.; Tosi, P.; Olivieri, A.; Rota-Scalabrini, D.; Cangialosi, C.; Cavo, M.; Corradini, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS). (23rd June 2022) Authors: Sgherza, N.; Curci, P.; Rizzi, R.; Roccotelli, D.; Croce, M.; Avantaggiato, M.; Ruga, L.; Vitucci, A.; Palma, A.; Di Gennaro, D.; Musto, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS. (23rd June 2022) Authors: Bruzzese, A.; Derudas, D.; Galli, M.; Martino, E. A.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangicavalli, S.; Farina, G.; Lombardo, A.; Brunori, M.; Rossi, E.; Antonioli, E.; Ria, R.; Zambello, R.; Di Renzo, N.; Mele, G.; Marcacci, G.; Pietrantuono, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. "Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese". Issue 3 (March 2015) Authors: Mele, G.; Melpignano, A.; Quarta, G.; Palumbo, G.; Capalbo, S.; Falcone, A.; Cascavilla, N.; Palazzo, G.; Mazza, P.; Iannitto, E.; Curci, P.; Rizzi, R.; Specchia, G.; Rossini, B.; Pavone, V.; Ria, R.; Vacca, A.; Buquicchio, C.; Tarantini, G.; Minoia, C. Journal: Leukemia research Issue: Volume 39:Issue 3(2015:Mar.) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗